6. Parkinson disease Clinical trials / Disease details
Clinical trials : 2,298 / Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202
Showing 1 to 6 of 6 diseases
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04863118 (ClinicalTrials.gov) | June 1, 2021 | 11/4/2021 | Acute Effects of Strength Training and High Intensity Training on Functional and Biochemical Measurements of Individuals With Parkinson's Disease in Different Environments and Depths Acute Effects of Strength Training and High Intensity Training on Functional and Biochemical Measure ... | Acute Effects of Strength Training in Shallow Water and Dry Land and High-intensity Training in Shallow and Deep Water, on Functional Measures and Biochemistries of Individuals With Parkinson's Disease Acute Effects of Strength Training in Shallow Waterand Dry Land and High-intensity Training in Shall ... | Parkinson Disease and Hydrotherapy | Other: Strength training in shallow water and dry land;Other: High-intensity training in shallow and deep water Other: Strength training in shallow waterand dry land;Other: High-intensity training in shallow and ... | Federal University of Health Science of Porto Alegre | NULL | Not yet recruiting | 50 Years | 70 Years | All | 60 | N/A | NULL |
2 | ChiCTR1900025894 | 2019-09-11 | 2019-09-12 | Parallel randomized controlled trial for Shengyang Yiwei Granule in the treatment of early Parkinson's disease Parallel randomized controlled trial for Shengyang Yiwei Granule in the treatment of early Parkinson ... | Parallel randomized controlled trial for Shengyang Yiwei Granule in the treatment of early Parkinson's disease Parallel randomized controlled trial for Shengyang Yiwei Granule in the treatment of early Parkinson ... | parkinson disease | experimental group:Parkinson's disease routine medication, plus Shengyang Yiwei granules, water blunt, one dose, morning and evening;control group:Parkinson's disease routine medication, add Buzhong Yiqi granules, water blunt, one dose, morning and evening; experimental group:Parkinson's disease routine medication, plus Shengyang Yiwei granules, waterblunt ... | Kaida Wang | NULL | Recruiting | Both | experimental group:45;control group:23; | China | |||
3 | JPRN-UMIN000019654 | 2015/11/06 | 06/11/2015 | The effect of rich-hydrogen water drinking to gut peptide | Parkinson's disease, healthy control | hydrogen water natural water | Nagoya graduate school of medicine university | NULL | Pending | 20years-old | 80years-old | Male and Female | 40 | Not applicable | Japan | |
4 | JPRN-UMIN000019090 | 2015/11/04 | 01/11/2015 | Reduced form of CoenzymeQ10 for Parkinson's disease - open trial of dose finding test and combination with hydrogen water Reduced form of CoenzymeQ10 for Parkinson's disease - open trial of dose finding test and combinatio ... | Parkinson's disease | reduced form of CoQ10 300mg 16weeks reduced form of CoQ10 600mg 16weeks reduced form of CoQ10 600mg 16weeks hydrogen water 500ml(Suisosui 7.0) 16weeks reduced form of CoQ10 300mg 16weeks reduced form of CoQ10 600mg 16weeks reduced form of CoQ10 600mg 16 ... | Juntendo University Koshigaya Hospital | NULL | Complete: follow-up complete | 20years-old | 80years-old | Male and Female | 45 | Not selected | Japan | |
5 | JPRN-UMIN000010014 | 2013/02/28 | 13/02/2013 | Randomized Double-blind, Placebo-controlled multi-center trial on molecular hydrogen water in Parkinson Disease Randomized Double-blind, Placebo-controlled multi-center trial on molecular hydrogen waterin Parkins ... | Parkinson's disesase | hydrogen water made by "Suisosui5.0" placebo-water (nitrogen filling water) | Juntendo University School of Medicine, Neurology | NULL | Complete: follow-up complete | 20years-old | Not applicable | Male and Female | 200 | Not selected | Japan | |
6 | JPRN-UMIN000007497 | 2010/01/01 | 14/03/2012 | Trial of molecular hydrogen water in Parkinson disease | Parkinson disease | The subjects should make 1000 ml of molecular hydrogen water which contains 1.6 ppm dissolved hydrogen by Aquerable, and consume for 48 weeks. Placebo water which is not contained molecular hydrogen water made from pseudo-machine. The subjects consume for48 weeks. The subjects should make 1000 ml of molecular hydrogen waterwhich contains 1.6 ppm dissolved hydroge ... | Department of Neurology, Juntendo University School of Medicine | NULL | Complete: follow-up complete | 20years-old | Not applicable | Male and Female | 18 | Not applicable | Japan |